Remeco PROLADII 250mg 10 Sachets Lemon Flavor 1.15g per Sachet

Description

Remeco PROLADII 250mg 10 Sachets Lemon Flavor 1.15g per Sachet – Digestion Health

# Documented high safety profile
Clinically proven for even 1 month and above.

# Evidence based to treat & aid recovery from acute diarrhea
S. boulardii significantly reduces the stool frequency & duration of acute diarrhea by approximately one day.

# For prevention of antibiotic associated diarrhea
The ESPGHAN WG recommends the use of S. boulardii for the prevention of AAD and C. difficile-associated diarrhea.

# 5 billion CFU
Sufficient live microorganism for action/

# Enhanced effectiveness with prebiotic
Inulin promotes the growth and activity of gut friendly bacteria.

Storage Condition:
Store below 30°C. Protect from light and moisture.

Content:
Each sachet contains a minimum Saccharomyces boulardii CNCM I-1079 of 5 x 109 CFU (freeze-dried yeast cells), Inulin 450mg, Maltodextrin 300mg and Lemon Powder (IPRONA).

Indications/Uses:
Treatment of acute diarrhoea in children and adults. Prevention of antibiotic-associated diarrhoea in children and adults. Prevention of tube feeding associated diarrhoea and Clostridium difficile recurrence in adults.

Dosage:
Children: 1 sachet once daily. Adults: 1 or 2 sachets twice daily.
Duration of treatment: Acute infectious diarrhoea: Approximately 1 week. Prevention of antibioticassociated diarrhoea: Start treatment within 48-72 hours, continue for at least 3 days and not >4 weeks. Prevention of Clostridium difficile recurrence: Start as soon as possible and continue for 4 weeks. Prevention of tube-feeding associated diarrhoea: During the period of tube-feeding. Max duration of treatment in the usual indications is 4 weeks.

Administration:
Pour the contents of the sachet in a glass of water or sweetened beverage, mix, and drink. Do not mix with very hot (over 50°C), iced or alcoholic drinks or food. The sachets can be taken either during, before or after meals.

Contraindications:
Hypersensitivity. Patients with central venous catheter. Critically ill or immunocompromised patients due to risk of fungaemia.